Pharmaceutical companies headquartered in Cambridge

Biogenbiogen.com

Company pioneers innovative science, delivering new medicines to transform patients' lives, with a global presence and focus on superior treatment outcomes.

Modernamodernatx.com

Pioneering mRNA technology for new medicines to improve patient lives by providing real-time instructions for protein production in cells

BeOne Medicinesbeonemedicines.com

Developing innovative, affordable cancer treatments for hematology and solid tumors with a global team and collaborative approach.

Alnylam Pharmaceuticalsalnylam.com

A global biotech company pioneering RNAi therapeutics to treat rare genetic diseases, with a breakthrough product and a robust pipeline

BeiGenebeonemedicines.com

Global oncology company developing accessible and affordable cancer treatments through innovative research, collaborations, and commitment to improving medicine access for patients worldwide

Cytelcytel.com

Global expertise in consulting, data-driven analytics, and software solutions for biotech and pharma companies to make confident, data-driven decisions in life sciences

Takeda Oncologytakedaoncology.com

Global oncology business unit leveraging transformative medicines to treat hematologic cancers and solid tumors, driving innovation through partnerships and cutting-edge science

Sarepta Therapeuticssarepta.com

Development of precision genetic medicines targeting rare diseases with significant impact on patients' lives and futures.

Flagship Pioneeringflagshippioneering.com

Innovative biotechnology company creating platform companies for transformative human health and sustainability products, with over 100 ventures in its ecosystem

Blueprint Medicinesblueprintmedicines.com

Develop targeted medicines addressing allergy, inflammation, oncology, and hematology by focusing on root causes and advancing clinical programs.

Agios Pharmaceuticalsagios.com

Commercial-stage biopharmaceutical company focused on developing and delivering innovative medicines for rare diseases, rooted in hematology, reflecting patient priorities.

Beam Therapeuticsbeamtx.com

Pioneering CRISPR base editing technology to develop precision genetic medicines for life-long cures, while fostering a community of fearless innovators

Vericel® Corporationvcel.com

A leading provider of advanced cell therapies and specialty biologics for sports medicine and severe burn care markets Core values include integrity, teamwork, and innovation

Intellia Therapeutics, Inc.intelliatx.com

Leading genome editing company focusing on developing curative gene editing treatments using CRISPR/Cas9 technology to transform the lives of patients with severe diseases

BlueRock Therapeuticsbluerocktx.com

A leading engineered cell therapy company developing regenerative medicines for neurology, cardiology, and immunology indications through innovative cell+gene platform

Wave Life Scienceswavelifesciences.com

Biotechnology company harnessing RNA medicines to develop treatments for various disorders, including rare diseases like Duchenne muscular dystrophy and prevalent conditions like obesity

XtalPi Inc.en.xtalpi.com

A quantum physics-based, AI-powered drug R&D company revolutionizing drug discovery with integrated technology platform and support from renowned investors

Cerevel Therapeuticscerevel.com

Biopharmaceutical company developing therapies for central nervous system disorders, with a portfolio targeting Parkinson's, Alzheimer's, epilepsy, schizophrenia, and addiction

Scholar Rockscholarrock.com

Biopharmaceutical company specializing in developing therapies targeting protein growth factors to treat serious diseases with high unmet need

Nuvalent, Inc.nuvalent.com

Precision oncology company developing targeted therapies for cancer patients, utilizing structure-based design to create innovative small molecules for improved outcomes and reduced side effects

Parabilis Medicinesparabilismed.com

FogPharma is developing HeliconTM peptides, a new drug modality that combines monoclonal antibodies with small molecules for broad, efficient drug targeting

Akcea Therapeuticsionispharma.com

Specializing in RNA therapeutics, we commercialize medicines and advance a pipeline of novel treatments, prioritizing bringing transformative drugs to patients globally

Editas Medicineeditasmedicine.com

A clinical stage genome editing company focused on using CRISPR technology to develop transformative treatments for serious diseases worldwide

Mispromispro.com

An accredited contract vivarium organization offering vivarium research space, animal care, and compliance services for preclinical rodent studies in North America

TCR² Therapeutics Inc.tcr2.com

Clinical-stage cell therapy company developing novel T cell therapies targeting solid tumors by utilizing TCR Fusion Construct T cells to kill cancer cells

Torquetorquetx.com

Specializing in immuno-oncology, innovative Deep Primed™ cell therapies are developed to activate and target immune responses within the tumor microenvironment

Akamis Bioakamisbio.com

Clinical stage oncology company pioneering systemic immune oncology products. Focuses on reprogramming the tumor microenvironment to overcome resistance to therapy with a rapidly expanding pipeline.

HiFiBiO Therapeuticshifibio.com

A multinational biotherapeutics company leveraging single-cell profiling technologies to develop antibody drugs for cancer and autoimmune disorders, fostering open-innovation partnerships

LifeCanvas Technologies Inc.lifecanvastech.com

A bioimaging company founded at MIT, revolutionizing intact tissue spatial biology with end-to-end solutions for research, drug discovery, and personalized medicine

Zumutor Biologicszumutor.com

Innovative biotech company developing immuno onco-therapeutics using proprietary antibody discovery technology to enhance NK cell engagement for cancer treatment

Novartis Sciencenovartis.com

A global team of over 6,000 professionals focusing on innovative drug discovery in various disease areas with key technology competencies

New Health Sciences, Inc.newhealthsciences.com

Developing technology to enhance transfusion therapy by improving safety and efficacy of red blood cells storage, extending shelf life and quality

Design Pharmaceuticals Inc.designpharmaceuticals.com

Innovative pharmaceutical company using ultra-high throughput bioscience technologies to accelerate GPCR drug discovery and develop novel therapeutics